180 related articles for article (PubMed ID: 16536457)
1. Functionalization and cellular uptake of boron carbide nanoparticles. The first step toward T cell-guided boron neutron capture therapy.
Mortensen MW; Björkdahl O; Sørensen PG; Hansen T; Jensen MR; Gundersen HJ; Bjørnholm T
Bioconjug Chem; 2006; 17(2):284-90. PubMed ID: 16536457
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of Boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy.
Mortensen MW; Sørensen PG; Björkdahl O; Jensen MR; Gundersen HJ; Bjørnholm T
Appl Radiat Isot; 2006 Mar; 64(3):315-24. PubMed ID: 16290943
[TBL] [Abstract][Full Text] [Related]
3. Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model.
Petersen MS; Petersen CC; Agger R; Sutmuller M; Jensen MR; Sørensen PG; Mortensen MW; Hansen T; Bjørnholm T; Gundersen HJ; Huiskamp R; Hokland M
Anticancer Res; 2008; 28(2A):571-6. PubMed ID: 18506994
[TBL] [Abstract][Full Text] [Related]
4. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
[TBL] [Abstract][Full Text] [Related]
5. T cell uptake for the use of boron neutron capture as an immunologic research tool.
Binello E; Mitchell RN; Harling OK
Appl Radiat Isot; 2004 Nov; 61(5):959-62. PubMed ID: 15308175
[TBL] [Abstract][Full Text] [Related]
6. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
7. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
[TBL] [Abstract][Full Text] [Related]
8. Neutron capture nuclei-containing carbon nanoparticles for destruction of cancer cells.
Hwang KC; Lai PD; Chiang CS; Wang PJ; Yuan CJ
Biomaterials; 2010 Nov; 31(32):8419-25. PubMed ID: 20701966
[TBL] [Abstract][Full Text] [Related]
9. Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy.
Miyajima Y; Nakamura H; Kuwata Y; Lee JD; Masunaga S; Ono K; Maruyama K
Bioconjug Chem; 2006; 17(5):1314-20. PubMed ID: 16984142
[TBL] [Abstract][Full Text] [Related]
10. [Lethal effect of boron neutron capture reaction on human uveal melanoma cells in culture incubated with borophenylalanine].
Belkhou R; Mykita S; Meyer L; Sahel J; Abbé JC; Dreyfus H; Massarelli R
C R Acad Sci III; 1992; 315(12):485-91. PubMed ID: 1297526
[TBL] [Abstract][Full Text] [Related]
11. Development of boron nanocapsules for neutron capture therapy.
Nakamura H; Ueno M; Ban HS; Nakai K; Tsuruta K; Kaneda Y; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S84-7. PubMed ID: 19406654
[TBL] [Abstract][Full Text] [Related]
12. MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters.
Geninatti-Crich S; Alberti D; Szabo I; Deagostino A; Toppino A; Barge A; Ballarini F; Bortolussi S; Bruschi P; Protti N; Stella S; Altieri S; Venturello P; Aime S
Chemistry; 2011 Jul; 17(30):8479-86. PubMed ID: 21671294
[TBL] [Abstract][Full Text] [Related]
13. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
[TBL] [Abstract][Full Text] [Related]
14. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.
Yanagie H; Maruyama K; Takizawa T; Ishida O; Ogura K; Matsumoto T; Sakurai Y; Kobayashi T; Shinohara A; Rant J; Skvarc J; Ilic R; Kuhne G; Chiba M; Furuya Y; Sugiyama H; Hisa T; Ono K; Kobayashi H; Eriguchi M
Biomed Pharmacother; 2006 Jan; 60(1):43-50. PubMed ID: 16260113
[TBL] [Abstract][Full Text] [Related]
15. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
Pisarev MA; Dagrosa MA; Thomasz L; Juvenal G
Medicina (B Aires); 2006; 66(6):569-73. PubMed ID: 17240633
[TBL] [Abstract][Full Text] [Related]
16. Next generation adoptive immunotherapy--human T cells as carriers of therapeutic nanoparticles.
Mortensen MW; Kahns L; Hansen T; Sorensen PG; Björkdahl O; Jensen MR; Gundersen HJ; Bjørnholm T
J Nanosci Nanotechnol; 2007 Dec; 7(12):4575-80. PubMed ID: 18283847
[TBL] [Abstract][Full Text] [Related]
17. In vitro neutron irradiation of glioma and endothelial cultured cells.
Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
[TBL] [Abstract][Full Text] [Related]
18. L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors.
Detta A; Cruickshank GS
Cancer Res; 2009 Mar; 69(5):2126-32. PubMed ID: 19244126
[TBL] [Abstract][Full Text] [Related]
19. Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy.
Ma L; Hamdi J; Wong F; Hawthorne MF
Inorg Chem; 2006 Jan; 45(1):278-85. PubMed ID: 16390066
[TBL] [Abstract][Full Text] [Related]
20. EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation.
Kullberg EB; Wei Q; Capala J; Giusti V; Malmström PU; Gedda L
Int J Radiat Biol; 2005 Aug; 81(8):621-9. PubMed ID: 16298943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
